NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase JOBY Q1 2026 Earnings EPS Beat by 39 Highlights Progress in eVTOL Development Path Pineapple Financial Inc PAPL Q3 2025 Earnings Narrowing Losses Beat Expectations Yet Shares Slip Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress ATLCP Q1 2026 Earnings Earnings Per Share Surpasses Estimates by Nearly 26 EVGO Q1 2026 Earnings NarrowerThanExpected Loss Despite Limited Revenue Disclosure